NuVasive, Inc.

Nuvasive, Inc. is a medical device company in the spine market. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The Company offers two product lines: spine surgery products and biologics. The Company's spine surgery products line offerings include thoracolumbar product offerings, cervical product offerings, Intra-Operative Monitoring (IOM) services and disposables, which are used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The Company's biologics product line offerings includes allograft (donated human tissue), FormaGraft (a collagen synthetic product), Osteocel Plus and Osteocel Pro (each an allograft cellular matrix containing viable mesenchymal stem cells (MSCs)), and AttraX (a synthetic bone graft material), all of which are used to aid the spinal fusion or bone healing process.  
 

News

NuVasive, Inc.'s (NASDAQ:NUVA) Speed of Innovation and Absolute Responsiveness form the Backbone of its Rapid Growth

🕔12/15/2016 8:30:00 AM 980

How does a start-up venture capital-backed company grow its revenues to nearly a billion dollars in the global spine industry in less than two decades? By developing a competitive advantage in Speed of Innovation(R) and Absolute Responsiveness(R), two concepts that have made NuVasive, Inc. (NASDAQ:NUVA) the number three company in the spine industry with over 90 products in its portfolio, including lumbar, thoracic, and cervical applications; neuromonitoring services; and biologics solutions.

Read Full Article
###

624 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 5) (Last 30 Days: 10) (Since Published: 624) 

Company Data